The beneficial impact on stroke risk appeared to be greater in patients age 79 and younger than in the older patients examined.
The multiple sclerosis expert at the University of Pennsylvania detailed the thought process behind treating the disease with high efficacy drugs at an early stage.

SAP Partner Banner